BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBIO
2901
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $103K | ﹤0.01% |
3,738
-10,404
| -74% | -$204K |
|
2902
Elbit Systems
ESLT
$36.5B
| $103K | ﹤0.01% |
790
| – | – |
|
2903
Microvision
MVIS
$89.7M
| $102K | ﹤0.01% |
+407
| New | +$100K |
|
2904
Cass Information Systems
CASS
$750M
| $102K | ﹤0.01% |
2,491
-120
| -5% | -$5.4K |
|
|
NWLI
2905
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $101K | ﹤0.01% |
452
-831
| -65% | -$198K |
|
2906
QCR Holdings
QCRH
$1.75B
| $101K | ﹤0.01% |
2,098
-4,412
| -68% | -$211K |
|
2907
POSCO
PKX
$17.1B
| $101K | ﹤0.01% |
1,312
-371
| -22% | -$29.4K |
|
2908
Camden National
CAC
$996M
| $101K | ﹤0.01% |
2,106
-4,490
| -68% | -$213K |
|
2909
Argan
AGX
$7.84B
| $100K | ﹤0.01% |
2,097
-4,921
| -70% | -$245K |
|
2910
Stock Yards Bancorp
SYBT
$2.64B
| $100K | ﹤0.01% |
1,968
-6,108
| -76% | -$316K |
|
2911
HSBC
HSBC
$358B
| $100K | ﹤0.01% |
3,471
+2,110
| +155% | +$64.4K |
|
2912
Modine Manufacturing
MOD
$10.8B
| $99.9K | ﹤0.01% |
6,023
-17,549
| -74% | -$287K |
|
2913
PUT
HP
HPQ
$28.6B
| $99.6K | ﹤0.01% |
33
| – | – |
|
2914
Vishay Precision Group
VPG
$908M
| $99.4K | ﹤0.01% |
2,920
-2,780
| -49% | -$92.3K |
|
2915
Veracyte
VCYT
$3.42B
| $99K | ﹤0.01% |
2,475
-5,690
| -70% | -$243K |
|
|
THR
2916
DELISTED
Thermon Group Holdings
THR
| $98.6K | ﹤0.01% |
5,784
-10,027
| -63% | -$187K |
|
2917
AppFolio
APPF
$7.22B
| $98.4K | ﹤0.01% |
697
-1,565
| -69% | -$217K |
|
2918
Personalis
PSNL
$1.54B
| $98.1K | ﹤0.01% |
3,879
+373
| +11% | +$8.54K |
|
|
XLRN
2919
DELISTED
Acceleron Pharma
XLRN
| $98.1K | ﹤0.01% |
782
+705
| +916% | +$88.9K |
|
|
SRNE
2920
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $97.9K | ﹤0.01% |
10,105
-22,121
| -69% | -$176K |
|
|
DRNA
2921
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $97K | ﹤0.01% |
2,600
-11,517
| -82% | -$353K |
|
2922
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
| $96.7K | ﹤0.01% |
560
+166
| +42% | +$27.4K |
|
2923
Calix
CALX
$2.51B
| $96.4K | ﹤0.01% |
2,030
-5,336
| -72% | -$234K |
|
|
AXNX
2924
DELISTED
Axonics, Inc. Common Stock
AXNX
| $95.2K | ﹤0.01% |
1,501
-2,405
| -62% | -$142K |
|
2925
Red Rock Resorts
RRR
$3.67B
| $94.9K | ﹤0.01% |
2,232
-40,911
| -95% | -$1.62M |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.